TissueGene Inc (950160)

Currency in KRW
71,500
-8,100(-10.18%)
Closed·
Unusual trading volume
950160 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
63,20079,800
52 wk Range
23,70088,700
Key Statistics
Bid/Ask
71,500.00 / 71,600.00
Prev. Close
79,600
Open
79,600
Day's Range
63,200-79,800
52 wk Range
23,700-88,700
Volume
1.57M
Average Volume (3m)
592.86K
1-Year Change
212.69%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
950160 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
150,000
Upside
+109.79%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to drop this year

TissueGene Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

TissueGene Inc Company Profile

Kolon TissueGene, Inc. develops cell therapies for orthopedic diseases and other unmet medical needs. The company’s lead product is the TG-C that has completed Phase II trials to treat osteoarthritis, as well as rheumatoid arthritis, meniscus, and spinal discs. It is also developing cell therapies for musculoskeletal system disorders, as well as vet medicine. Kolon TissueGene, Inc. was formerly known as TissueGene, Inc. and changed its name to Kolon TissueGene, Inc. in March 2018. The company was founded in 1999 and is headquartered in Rockville, Maryland.

Compare 950160 to Peers and Sector

Metrics to compare
950160
Peers
Sector
Relationship
P/E Ratio
−75.7x−4.6x−0.6x
PEG Ratio
0.21−0.080.00
Price/Book
35.9x4.0x2.6x
Price / LTM Sales
1,304.8x61.7x3.2x
Upside (Analyst Target)
109.8%41.1%43.2%
Fair Value Upside
Unlock11.3%6.6%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 150,000
(+109.79% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 14, 2025
EPS / Forecast
-76.20 / --
Revenue / Forecast
1.72B / --
EPS Revisions
Last 90 days

950160 Income Statement

People Also Watch

121,500
007660
+1.93%
63,000.00
466100
0.00%
457,000
196170
+1.67%
443,000
128940
-1.99%
47,950
353200
+1.80%

FAQ

What Is the TissueGene (950160) Stock Price Today?

The TissueGene stock price today is 71,500

What Stock Exchange Does TissueGene Trade On?

TissueGene is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for TissueGene?

The stock symbol for TissueGene is "950160."

What Is the TissueGene Market Cap?

As of today, TissueGene market cap is 5.95T.

What Is TissueGene's Earnings Per Share (TTM)?

The TissueGene EPS (TTM) is -1,074.77.

From a Technical Analysis Perspective, Is 950160 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has TissueGene Stock Split?

TissueGene has split 0 times.

What is the current trading status of TissueGene (950160)?

As of Jan 03, 2026, TissueGene (950160) is trading at a price of 71,500, with a previous close of 79,600. The stock has fluctuated within a day range of 63,200 to 79,800, while its 52-week range spans from 23,700 to 88,700.

What Is TissueGene (950160) Price Target According to Analysts?

The average 12-month price target for TissueGene is KRW150000, with a high estimate of KRW150000 and a low estimate of KRW150000. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +109.79% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.